New patent for Anacor Pharms drug KERYDIN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for KERYDIN
Annual Drug Patent Expirations for KERYDIN

Kerydin is a drug marketed by Anacor Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.

KERYDIN drug price trends.

Drug patent litigation for KERYDIN.

The generic ingredient in KERYDIN is tavaborole. One supplier is listed for this compound. Additional details are available on the tavaborole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top